Diphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor

盐酸苯海拉明/苯佐卡因/薄荷脑/樟脑

Report date: 2025/07/18 17:32:57

Base Information

Drug NameDiphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor
Drug Alias Name复方苯海拉明搽剂
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor inverse agonistsSodium channel alpha subunit blockersTransient receptor potential cation channel subfamily M member 8 agonists
TargetsHistamine H1 receptorSodium channel alpha subunitTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsPruritusDermatitis, Atopic
Global Approved IndicationsPruritusDermatitis, Atopic
Approved Indications in ChinaPruritusDermatitis, Atopic
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsYes Diphenhydramine HydrochlorideBenzocaineMenthol
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Shuguang Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsPruritusDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A